Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Prospective, multi-center, non-randomized registry / study, up to 164 patients enrolled and followed at 180 days +/- 45 days and again at 365 days +/- 90 days post procedure
Assess and describe real world clinical data on i-ED coils Characterize the acute and long-term performance of iED coils when used for treating for an intracranial aneurysm May be used alone or in combination with other adjunctive device(s)
Study Duration
Anticipated timeline for study:
Patient enrollment in 18 - 24 months Completion of follow-up 12 months after last patient enrolled
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Interventional treatment | Other | Open label |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| i-ED COIL | Device | The i-ED COIL System (i-ED COIL and detachment box) are intended for the endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. |
| Measure | Description | Time Frame |
|---|---|---|
| Adequate Occlusion | Proportion of subjects who achieve Adequate Occlusion (Modified Raymond-Roy I or II Classification) | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Complete Occlusion | Complete occlusion at 1 year (Modified Raymond-Roy I) | 12 months |
| Packing Density | Aneurysm volume and percent of aneurysm packing for coil embolization. Packing density will be evaluated based on aneurysm volume and coil volume |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ajit Puri, MD | University of Massachusetts, Worcester | Principal Investigator |
| Mohamed Hussain, MD | The Cleveland Clinic | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| McLaren Health Care | Grand Blanc | Michigan | 48439 | United States | ||
| Northwell Health Lenox Hill Hospital |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002532 | Intracranial Aneurysm |
| D000783 | Aneurysm |
| ID | Term |
|---|---|
| D020765 | Intracranial Arterial Diseases |
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| 12 months |
| Modified Rankin Score | Modified Rankin Score (Scale from 0-6), the lower the score the better - 0 No symptoms and 6 is dead.
| 12 months |
| Retreatment | Any retreatment of the aneurysm, surgically or interventional embolization | 12 months |
| Adverse events | Device or procedure related adverse events | 12 months |
| New York |
| New York |
| 10075 |
| United States |
| Cleveland Clinic | Cleveland | Ohio | 44195 | United States |
| SSM Health St. Anthony's Hospital | Oklahoma City | Oklahoma | 73102 | United States |
| D009422 | Nervous System Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |